Inhibition of the Human Neutrophil Respiratory Burst by Native and Synthetic Surfactant

American Journal of Respiratory Cell and Molecular Biology

Volumn 14, Issue 5, 1996, Pages 496-503

  Ahuja, Anita ^b   Oh, Nancy ^b   Chao, Wei ^b   Spragg, Roger G ^b   Smith, Robert M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SUIDAE;

1 PALMITOYL 2 OLEOYLGLYCERO 3 PHOSPHOGLYCEROL; 1-PALMITOYL-2-OLEOYLGLYCERO-3-PHOSPHOGLYCEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE RECEPTOR; IMMUNOGLOBULIN RECEPTOR; LACTOFERRIN; LIPOSOME; LUNG SURFACTANT; PEPTIDE FRAGMENT; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDIC ACID; PHOSPHATIDYLGLYCEROL; PROTEIN KINASE C; RECEPTOR; SUPEROXIDE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; HUMAN; IN VITRO STUDY; KINETICS; MOLECULAR GENETICS; NEUTROPHIL; PHYSIOLOGY; RESPIRATORY BURST; SWINE;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; AMINO ACID SEQUENCE; ANIMALS; HUMANS; KINETICS; LACTOFERRIN; LIPOSOMES; MOLECULAR SEQUENCE DATA; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PEPTIDE FRAGMENTS; PHOSPHATIDIC ACIDS; PHOSPHATIDYLGLYCEROLS; PROTEIN KINASE C; PULMONARY SURFACTANTS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PEPTIDE; RESPIRATORY BURST; SUPEROXIDES; SWINE; TETRADECANOYLPHORBOL ACETATE;

EID: 0030138080     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.14.5.8624255     Document Type: Article

References (42)

1. Lewis, J. F., and A. H. Jobe. 1993. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147:218-233.
2. Gregory, T. J., W. J. Longmore, M. A. Moxley, J. A. Whitsett, C. R. Reed, A. A. Fowler, L. D. Hudson, R. J. Maunder, C. Crim, and T. M. Hyers. 1991. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88:1976-1981.
3. Spragg, R. G., N. Gilliard, P. M. Richman, R. M. Smith, R. D. Hite, D. Pappert, B. Robertson, T. Curstedt, and D. Strayer. 1994. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 105:195-202.
4. Weg, J. G., R. A. Balk, R. S. Tharratt, S. G. Jenkinson, J. B. Shah, D. Zaccardelli, J. Horton, and E. N. Pattishall. 1994. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA 272:1433-1438.
5. Corbet, A., R. Bucciarelli, S. Goldman, M. Mammel, D. Wold, W. Long, and American Exosurf Pediatric Study Group I. 1991. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. J. Pediatr. 118: 277-284.
6. Spragg, R. G., and R. M. Smith. 1993. Biology of actue lung injury. In The Lung: Scientific Foundations. R. G. Crystal and J. B. West, editors. Raven Press, New York. 2003-2018.
7. Weiland, J. E., W. B. Davis, J. F. Holler, J. R. Mohammed, P. M. Dorinsky, and J. E. Gadek. 1986. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance Am. Rev. Respir. Dis. 133:218-225.
8. Tate, R. M., and J. E. Repine. 1983. Neutrophils and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 128:552-559.
9. Bartmann, P., L. Gortner, F. Pohlandt, and H. Jaeger. 1992. In vitro lymphocyte functions in the presence of bovine surfactant and its phospholipid fractions. J. Perinat. Med. 20:189-196.
10. Speer, C. P., B. Gotze, T. Curstedt, and B. Robertson. 1991. Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr. Res. 30:69-74.
11. Thomassen, M. J., J. M. Antal, M. J. Connors, D. P. Meeker, and H. P. Wiedemann. 1994. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. Am. J. Respir. Cell Mol. Biol. 10:399-404.
12. Blau, H., S. Riklis, V. Kravtsov, and M. Kalina. 1994. Secretion of cytokines by rat alveolar epithelial cells: possible regulatory role for SP-A. Am. J. Physiol. 266:L148-L155.
13. van Iwaarden, F., B. Welmers, J. Verhoef, H. P. Haagsman, and L. M. Van Golde. 1990. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 2:91-98.
14. Wright, J. R., and D. C. Youmans. 1993. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am. J. Physiol. 264: 6338-6344.
15. Webb, D. S., and E. L. Jeska. 1986. Enhanced luminol-dependent chemiluminescence of stimulated rat alveolar macrophages by pretreatment with alveolar lining material. J. Leukoc. Biol. 40:55-64.
16. Hayakawa, H., Q. N. Myrvik, and R. W. St. Clair. 1989. Pulmonary surfactant inhibits priming of rabbit alveolar macrophage: evidence that surfactant suppresses the oxidative burst of alveolar macrophage in infant rabbits. Am. Rev. Respir. Dis. 140:1390-1397.
17. Geertsma, M. F., H. R. Broos, M. T. van den Barselaar, P. H. Nibbering, and R. van Furth. 1993. Lung surfactant suppresses oxygen-dependent bactericidal functions of human blood monocytes by inhibiting the assembly of the NADPH oxidase. J. Immunol. 150:2391-2400.
18. Speer, C. P., B. Gotze, B. Robertson, and T. Curstedt. 1990. Einfluss von naturlichem porcinen Surfactant (Curosurf) auf die Funktion neutrophiler Granulozyten. [Effect of natural porcine surfactant (Curosurf) on the function of neutrophilic granulocytes] Monatsschr Kinderheilkd 138: 737-741.
19. Suziki, H., K. Otake, N. Yakuwa, A. Suwabe, S. Sato, H. Tomoike, and K. Takahashi. 1992. Effects of artificial surfactant on human peripheral blood polymorphonuclear neutrophil function. Am. Rev. Respir. Dis. 145:A876. (Abstr.)
20. Yoshida, K., and V. Mohsenin. 1991. Unsaturated phosphatidylcholines inhibit superoxide production in human neutrophils. Life Sci. 49:1359-1365.
21. Mayo, L. A., and J. T. Curnutte. 1990. Kinetic microplate assay for superoxide production by neutrophils and other phagocytic cells. Methods Enzymol. 186:567-574.
22. Markert, M., P. C. Andrews, and B. M. Babior. 1984. Measurement of O2-production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol. 105:358-365.
23. Katyal, S. L., L. W. Estes, and B. Lombardi. 1977. Method for the isolation of surfactant from homogenates and lavages of adult, newborn, and fetal rats. Lab. Invest. 36:585-592.
24. Revak, S. D., T. A. Merritt, M. Hallman, G. Heldt, R. J. La Polla, K. Hoey, R. A. Houghten, and C. G. Cochrane. 1991. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatr. Res. 29:460-465.
25. Cochrane, C. G., and S. D. Revak. 1991. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 254:566-568.
26. Enhorning, G. 1977. A pulsating bubble technique for evaluating pulmonary surfactant. J. Appl. Physiol. 43:198-201.
27. Krause, K.-H., W. Schlegel, C. B. Wollheim, T. Andersson, F. A. Waldvogel, and P. D. Lew. 1985. Chemotactic peptide activation of human neutrophils and HL-60 cells: pertussis toxin reveals correlation between inositol trisphosphate generation, calcium ion transients, and cellular activation. J. Clin. Invest. 76:1348-1354.
28. Lew, P. D., C. Wollheim, R. A. Seger, and T. Pozzan. 1984. Cytosolic free calcium changes induced by chemotactic peptide in neutrophils from patients with chronic granulomatous disease. Blood 63:231-233.
29. Wright, D. G. 1988. Human neutrophil degranulation. Methods Enzymol. 162:538-551.
30. Flohe, L., and F. Otting. 1984. Superoxide dismutaseassays. Methods Enzymol. 105:93-104.
31. Chanock, S. J., J. El Benna, R. M. Smith, and B. M. Babior. 1994. The respiratory burst oxidase. J. Biol. Chem. 269:24519-24522.
32. McPhail, L. C., and R. Snyderman. 1983. Activation of the respiratory burst oxidase in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli: evidence that the same oxidase is activated by different transductional mechanisms. J. Clin. Invest. 72:192-200.
33. Agwu, D. E., L. C. McPhail, S. Sozzani, D. A. Bass, and C. E. McCall. 1991. Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes: effects on activation of the NADPH oxidase. J. Clin. Invest. 88:531-539.
34. Hayakawa, H., G. Giridhar, Q. N. Myrvik, and L. Kucera. 1992. Pulmonary surfactant phospholipids modulate priming of rabbit alveolar macrophages for oxidative responses. J. Leukoc. Biol. 51:379-385.
35. Walker, B. A., and P. A. Ward. 1992. Priming and signal transduction in neutrophils. Biol. Signals 1:237-249.
36. Yoshida, K., and V. Mohsenin. 1994. Inhibition of protein kinase C of human neutrophils by phosphatidylcholines. Life Sci. 54:515-524.
37. Babior, B. M., R. Kuver, and J. T. Curnutte. 1988. Kinetics of activation of the respiratory burst oxidase in a fully soluble system from human neutrophils. J. Biol. Chem. 263:1713-1718.
38. phox membrane translocation as the mechanism. J. Clin. Invest. 96: 2654-2660.
39. +-forming oxidase responsible for the respiratory burst in human neutrophils: properties of the solubilized enzyme. J. Biol. Chem. 254:9070-9079.
40. +-generating NADPH oxidase. J. Biol. Chem. 265:8426-8430.
41. Effros, R. M. 1991. Permeability of the blood-gas barrier. In The Lung: Scientific Foundations. R. G. Crystal and J. B. West, editors. Raven Press, New York. 1163-1176.
42. Hallman, M., T. A. Merritt, M. Pohjavuori, and L. Gluck. 1986. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr. Res. 20: 1228-1235.